MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Constipation"

  • 2023 International Congress

    Management of constipation in Parkinson’s patients presenting with acute sigmoid volvulus to Royal Berkshire Hospital,Reading, UK

    M. Khwaja, S. Alam, E. Castaneda-Caicedo, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate management of constipation in acute sigmoid volvulus in Parkinson’s. Background: Constipation is one of the main and disabling non motor symptoms in…
  • 2023 International Congress

    Management of Sigmoid Volvulus in Parkinson’s patients presenting to Royal Berkshire Hospital, Reading ,UK.

    M. Khwaja, S. Alam, A. Chatterjee, E. Castaneda-Cicedo (Reading, United Kingdom)

    Objective: To evaluate acute management of volvulus in Parkinson’s Background: Constipation affects upto 50% of patients with Parkinson's and sigmoid volvulus is an under recognized…
  • 2023 International Congress

    Probiotics for treatment of constipation in Parkinson’s patients: a systematic review and meta-analysis

    M. Alsaied, A. Elettreby, A. Abo Elnaga, D. Kamal, G. Alderbi, A. Sharkawy, R. Fareed (Mansoura, Egypt)

    Objective: The objective of this systematic review and meta-analysis of published clinical trials is to investigate the probiotics' efficacy in treating constipation in Parkinson’s patients.…
  • 2023 International Congress

    Gut dysbiosis in Indian Parkinson’s Disease Patients with Constipation

    S. Pavan, M. Ballal, A. Prabhu, B. Das, A. Mutreja, K. Vasudevan (Manipal, India)

    Objective: To analyse the gut microbiome and explore dysbiosis in Indian Parkinson’s Disease patients with and without constipation. Background: Global studies have associated gut dysbiosis…
  • 2022 International Congress

    The Comparison of Constipation scoring system scales between Parkinson’s disease and non-Parkinson’s disease patients with constipation

    K. Methawasin, A. Krittayasingh, P. Chonmaitree, M. Wongwandee, N. Kongsakorn (Nakhon Nayok, Thailand)

    Objective: This study aims to identify differences of constipation symptoms in detail by using the constipation scoring system between PD patients and non-PD patients. Background:…
  • 2022 International Congress

    Characterization of gastrointestinal dysfunction in Parkinson’s by disease stage

    M. Camacho, J. Greenland, D. Apostolopoulos, C. Daruwalla, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To conduct a comprehensive cross-sectional and longitudinal characterization of gastrointestinal dysfunction (GID) in Parkinson’s disease (PD). Background: GID is an important feature of PD…
  • MDS Virtual Congress 2021

    The effect of Tuina in Traditional Chinese Medicine in treatment of Parkinson’s disease (Non-motor symptoms): a pilot clinical study

    FY. Chung, HY. Lai, CS. Yuen, HW. Lam, KY. Lai, SM. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)

    Objective: To evaluate the efficacy and safety of Tuina treatment in treating non-motor symptoms (NMS) of Parkinson’s disease (PD) and provide preliminary data for conducting…
  • MDS Virtual Congress 2021

    Effect of probiotics on MDS UPDRS in Parkinson disease at 12 weeks: A Randomized double-blind placebo-controlled trial

    G. George, T. Iype (Thiruvananthapuram, India)

    Objective: The primary objective was to find the effect of 12 weeks of probiotic supplementation on MDS UPDRS score in Parkinson’s Disease. The secondary objectives…
  • MDS Virtual Congress 2021

    Celiac disease-related antibodies in Parkinson’s Disease patients: a case control study.

    GUL. şahbaz, BOB. Barut, SDT. Tekol (Istanbul, Turkey)

    Objective: To compare anti-transglutaminase and antigliadin antibodies between Parkinson’s disease patients and healthy controls. A detailed gastrointestinal symptom investigation was studied and compared between patient…
  • MDS Virtual Congress 2021

    Secondary endpoints of a randomized, placebo-Controlled Pilot Study to evaluate the safety of lyophilized PRIM-DJ2727 in Parkinson’s disease

    J. Suescun, M. Schiess, Z. Jiang, V. Thyne, T. Iqbal, N. Utay, M. Newmark, A. Dupont, A. Alexander, H. Dupont (Houston, USA)

    Objective: To evaluate the impact of fecal microbiome transplant (FMT) on disease progression as a secondary outcome of a safety study using PRIM-DJ2727 in Parkinson's…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley